7-Substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro

Anticancer Research

Volumn 33, Issue 10, 2013, Pages 4347-4356

  Kiełbus, Michał ^a   Skalicka Woźniak, Krystyna ^a   Grabarska, Aneta ^a   Jeleniewicz, Witold ^a   Dmoszyńska Graniczka, Magdalena ^a   Marston, Andrew ^b   Polberg, Krzysztof ^c   Gawda, Piotr ^a   Klatka, Janusz ^a   Stepulak, Andrzej ^a,c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

^c Ministry of Interior and Administration Republic of Poland Central Clinical Hospital   (Poland)

Author keywords

Apoptosis; Cell cycle; Herniarin; High performance counter current chromatography; Laryngeal cancer cells; Migration; Proliferation; Scoparone; Umbelliferone

Indexed keywords

ANTINEOPLASTIC AGENT; HERNIARIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; SCOPARONE; UMBELLIFERONE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE PROGRESSION; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LARYNX CANCER; METASTASIS INHIBITION; MTT ASSAY; PRIORITY JOURNAL; TREATMENT OUTCOME; WESTERN BLOTTING;

APOPTOSIS; CELL CYCLE; HERNIARIN; HIGH-PERFORMANCE COUNTER CURRENT CHROMATOGRAPHY; LARYNGEAL CANCER CELLS; MIGRATION; PROLIFERATION; SCOPARONE; UMBELLIFERONE;

ACETATES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COUMARINS; FRUIT; HEPTANES; HERACLEUM; HUMANS; LARYNGEAL NEOPLASMS; METHANOL; PLANT EXTRACTS; SOLVENTS; UMBELLIFERONES; WATER;

EID: 84891361358     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Shikishima Y, Takaishi Y, Honda G, Ito M, Takfda Y, Kodzhimatov OK, Ashurmetov O and Lee KH: Chemical constituents of Prangos tschiniganica; Structure elucidation and absolute configuration of coumarin and furanocoumarin derivatives with anti-HIV activity. Chem Pharm Bull 49: 877-880, 2001.
2. Monti M, Pinotti M, Appendino G, Dallocchio F, Bellini T, Antognoni F, Poli F and Bernardi F: Characterization of anticoagulant properties of prenylated coumarin ferulenol. Biochim Biophys Acta 1770: 1437-1440, 2007.
3. Ostrov DA, Hernandez Prada JA, Corsino PE, Finton KA, Le N and Rowe TC: Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob Agents Chemother 51: 3688-3698, 2007.
4. Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE and Nicolaides DN: Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr Pharm Des 10: 3813-3833, 2004.
5. Elinos-Baez CM, Leon F and Santos E: Effects of coumarin and 7OH-coumarin on BCL-2 and BAX expression in two human lung cancer cell lines in vitro . Cell Biol Int 29: 703-708, 2005.
6. Jimenez-Orozco FA, Lopez-Gonzalez JS, Nieto-Rodriguez A, Velasco-Velazquez MA, Molina-Guarneros JA, Mendoza-Patino N, Garcia-Mondragon MJ, Elizalde-Galvan P, Leon-Cedeno F and Mandoki JJ: Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin. Lung Cancer 34: 185-194, 2001.
7. Kawaii S, Tomono Y, Ogawa K, Sugiura M, Yano M and Yoshizawa Y: The antiproliferative effect of coumarins on several cancer cell lines. Anticancer Res 21: 917-923, 2001.
8. Lopez-Gonzalez JS, Prado-Garcia H, Aguilar-Cazares D, Molina-Guarneros JA, Morales-Fuentes J and Mandoki JJ: Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer 43: 275-283, 2004.
9. Stefanova TH, Nikolova NJ, Toshkova RA and Neychev HO: Antitumor and immunomodulatory effect of coumarin and 7- hydroxycoumarin against Sarcoma 180 in mice. J Exp Ther Oncol 6: 107-115, 2007.
10. Lacy A and O'Kennedy R: Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des 10: 3797-3811, 2004.
11. Kahn J, Preis P, Waldman F and Tseng A Jr.: Coumarin modulates the cell-cycle progression of an MTV-EJras cell line. J Cancer Res Clin Oncol 120: S19-22, 1994.
12. Kofinas C, Chinou I, Loukis A, Harvala C, Roussakis C, Maillard M and Hostettmann K: Cytotoxic coumarins from the aerial parts of Tordylium apulum and their effects on a non-small-cell bronchial carcinoma line. Planta Medica 64: 174-176, 1998.
13. Yang XW, Xu B, Ran FX, Wang RQ, Wu J and Cui JR: Inhibitory effects of 11 coumarin compounds against growth of human bladder carcinoma cell line E-J in vitro . Zhong Xi Yi Jie He Xue Bao 5: 56-60, 2007 (in Chinese).
14. Huang HC, Hsieh LM, Chen HW, Lin YS and Chen JS: Effects of baicalein and esculetin on transduction signals and growth factors expression in T-lymphoid leukemia cells. Eur J Pharmacol 268: 73-78, 1994.
15. Kolodziej H, Kayser O, Woerdenbag HJ, vanUden W and Pras N: Structure - cytotoxicity relationships of a series of natural and semi-synthetic simple coumarins as assessed in two human tumour cell lines. Zeitschrift Fur Naturforschung C 52: 240-244, 1997.
16. Skalicka-Wozniak K and Glowniak K: Pressurized liquid extraction of coumarins from fruits of Heracleum leskowii with application of solvents with different polarity under increasing temperature. Molecules 17: 4133-4141, 2012.
17. Rzeski W, Paduch R, Klatka J, Kandefer-Szerszen M, Stepulak A, Pozarowski P and Zdzisinska B: Establishment and preliminary characterization of two cell lines derived from larynx carcinoma. Folia Histochem Cytobiol 40: 195-196, 2002.
18. Rzeski W, Stepulak A, Szymanski M, Sifringer M, Kaczor J, Wejksza K, Zdzisinska B and Kandefer-Szerszen M: Betulinic acid decreases expression of BCL-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn Schmiedebergs Arch Pharmacol 374: 11-20, 2006.
19. Chappell WH, Steelman LS, Long JM, Kempf RC, Abrams SL, Franklin RA, Basecke J, Stivala F, Donia M, Fagone P, Malaponte G, Mazzarino MC, Nicoletti F, Libra M, Maksimovic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Laidler P, Milella M, Tafuri A, Bonati A, Evangelisti C, Cocco L, Martelli AM and McCubrey JA: RAS/RAF/MEK/ERK and PI3K/PTEN/AKT/mTOR inhibitors: Rationale and importance to inhibiting these pathways in human health. Oncotarget 2: 135-164, 2011.
20. Mendoza MC, Er EE and Blenis J: The RAS-ERK and PI3KmTOR pathways: Cross-talk and compensation. Trends Biochem Sci 36: 320-328, 2011.
21. Belluti F, Fontana G, Dal Bo L, Carenini N, Giommarelli C and Zunino F: Design, synthesis and anticancer activities of stilbenecoumarin hybrid compounds: Identification of novel proapoptotic agents. Bioorg Med Chem 18: 3543-3550, 2010.
22. Gallicchio VS, Hulette BC, Harmon C and Marshall ME: Toxicity of coumarin (1,2-benzopyrone) on human peripheral blood mononuclear cells and human and murine bone marrow progenitor stem cells. J Biol Response Mod 8: 116-121, 1989.
23. Chu EA and Kim YJ: Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am 41: 673-695, v, 2008.
24. Cosetti M, Yu GP and Schantz SP: Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg 134: 370-379, 2008.
25. Freisen B and Pauli JB: G.U.E.S.S.-A Generally Useful Estimate of Solvent Systems for CCC. J Liquid Chromatogr Related Technol 28: 2777-2806, 2005.
26. Guzlek H, Baptista, II, Wood PL and Livingston A: A novel approach to modelling counter-current chromatography. J Chromatogr A 1217: 6230-6240, 2010.
27. Jang SI, Kim YJ, Kim HJ, Lee JC, Kim HY, Kim YC, Yun YG, Yu HH and You YO: Scoparone inhibits PMA-induced IL-8 and MCP-1 production through suppression of NF-kappaB activation in U937 cells. Life Sci 78: 2937-2943, 2006.
28. Finn GJ, Creaven BS and Egan DA: Activation of mitogen activated protein kinase pathways and melanogenesis by novel nitro-derivatives of 7-hydroxycoumarin in human malignant melanoma cells. Eur J Pharm Sci 26: 16-25, 2005.
29. Finn GJ, Creaven BS and Egan DA: Investigation of intracellular signalling events mediating the mechanism of action of 7-hydroxycoumarin and 6-nitro-7-hdroxycoumarin in human renal cells. Cancer Lett 205: 69-79, 2004.
30. Riveiro ME, De Kimpe N, Moglioni A, Vazquez R, Monczor F, Shayo C and Davio C: Coumarins: Old compounds with novel promising therapeutic perspectives. Curr Med Chem 17: 1325-1338, 2010.
31. Morohashi H, Kon A, Nakai M, Yamaguchi M, Kakizaki I, Yoshihara S, Sasaki M and Takagaki K: Study of hyaluronan synthase inhibitor, 4-methylumbelliferone derivatives on human pancreatic cancer cell (KP1-NL). Biochem Biophys Res Commun 345: 1454-1459, 2006.
32. Anttila MA, Tammi RH, Tammi MI, Syrjanen KJ, Saarikoski SV and Kosma VM: High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res 60: 150-155, 2000.
33. Itano N, Sawai T, Miyaishi O and Kimata K: Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res 59: 2499-2504, 1999.
34. Ropponen K, Tammi M, Parkkinen J, Eskelinen M, Tammi R, Lipponen P, Agren U, Alhava E and Kosma VM: Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res 58: 342-347, 1998.
35. Chi YS, Heo MY, Chung JH, Jo BK and Kim HP: Effects of the chestnut inner shell extract on the expression of adhesion molecules, fibronectin and vitronectin, of skin fibroblasts in culture. Arch Pharm Res 25: 469-474, 2002.